Molecular structure of Escitalopram, CAS Number: 128196-01-0
Escitalopram (CAS 128196-01-0)
See product citations (2)
Alternate Names:
S-(+)-Citalopram
Application:
Escitalopram is a selective serotonin reuptake inhibitor
CAS Number:
128196-01-0
Purity:
≥98%
Molecular Weight:
324.39
Molecular Formula:
C20H21FN2O
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Product Citations
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Escitalopram is a selective serotonin reuptake inhibitor (SSRI). Escitalopram works by increasing the levels of serotonin in the brain, which helps improve mood and reduce anxiety. Escitalopram is a highly potent and selective inhibitor of the reuptake of serotonin, with minimal effects on norepinephrine and dopamine reuptake. Escitalopram is a single isomer of the racemic compound citalopram.
Escitalopram (CAS 128196-01-0) References
- The clinical pharmacokinetics of escitalopram. | Rao, N. 2007. Clin Pharmacokinet. 46: 281-90. PMID: 17375980
- Escitalopram therapy for major depression and anxiety disorders. | Baldwin, DS., et al. 2007. Ann Pharmacother. 41: 1583-92. PMID: 17848424
- Escitalopram in the treatment of obsessive-compulsive disorder. | Zohar, J. 2008. Expert Rev Neurother. 8: 339-49. PMID: 18345966
- Escitalopram for the treatment of major depression and anxiety disorders. | Höschl, C. and Svestka, J. 2008. Expert Rev Neurother. 8: 537-52. PMID: 18416657
- Escitalopram versus other antidepressive agents for depression. | Cipriani, A., et al. 2009. Cochrane Database Syst Rev. CD006532. PMID: 19370639
- Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression. | Leonard, B. and Taylor, D. 2010. J Psychopharmacol. 24: 1143-52. PMID: 20147575
- Escitalopram: a review of its use in the management of major depressive disorder in adults. | Garnock-Jones, KP. and McCormack, PL. 2010. CNS Drugs. 24: 769-96. PMID: 20806989
- Escitalopram for the treatment of major depressive disorder in youth. | Ahn, JH. and Patkar, AA. 2011. Expert Opin Pharmacother. 12: 2235-44. PMID: 21895554
- Clinical pharmacology review of escitalopram for the treatment of depression. | Pastoor, D. and Gobburu, J. 2014. Expert Opin Drug Metab Toxicol. 10: 121-8. PMID: 24289655
- Efficacy of escitalopram in the treatment of social anxiety disorder: A meta-analysis versus placebo. | Baldwin, DS., et al. 2016. Eur Neuropsychopharmacol. 26: 1062-9. PMID: 26971233
- Escitalopram-induced hepatitis: A case report. | Wabont, G., et al. 2022. World J Clin Cases. 10: 2468-2473. PMID: 35434055
- Escitalopram-Induced Skin Rash: Dermatitis Medicamentosa. | Godi, SM. and Singh, LK. 2022. Indian J Dermatol. 67: 93. PMID: 35656231
- Escitalopram co-prescription in anastrozole-treated breast cancer patients. | Ozyurt, H., et al. 2022. North Clin Istanb. 9: 248-255. PMID: 36199859
Inhibitor of:
ASM, CYP2D6, CYP4AA3, Olr239, SLC6A (solute carrier family 6), Slc6a16, and SR-2A.Activator of:
Serotonin, and SR-3A.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Escitalopram, 10 mg | sc-357349 | 10 mg | $128.00 | |||
Escitalopram, 50 mg | sc-357349A | 50 mg | $408.00 |